A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Public ClinicalTrials.gov record NCT03725007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Study identification
- NCT ID
- NCT03725007
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- Upadacitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 23, 2019
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
- Last update posted
- Aug 4, 2025
2019 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago /ID# 211162 | Chicago | Illinois | 60611 | — |
| Duplicate_University of Louisville /ID# 202896 | Louisville | Kentucky | 40202 | — |
| Boston Children's Hospital /ID# 202993 | Boston | Massachusetts | 02115 | — |
| Cincinnati Childrens Hospital Medical Center /ID# 209697 | Cincinnati | Ohio | 45229 | — |
| Randall Children's Hospital /ID# 213609 | Portland | Oregon | 97227-1654 | — |
| Children's Hospital of Philadelphia /ID# 209617 | Philadelphia | Pennsylvania | 19146-2305 | — |
| Children's Hospital of Pittsburgh of UPMC /ID# 202994 | Pittsburgh | Pennsylvania | 15224-1334 | — |
| Seattle Children's Hospital /ID# 203003 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03725007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2025 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03725007 live on ClinicalTrials.gov.